Larry WeinerVP of Pharmaceutical Development & Manufacturing at Enzyvant Therapeutics
Agenda Sessions
Obtaining Commercial Approval for a Tissue Based Regenerative Medicine Product - A CMC Perspective
, 2:00pmView Session